Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH study

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 3, 2006, Pages

  Gomez, Pablo ^a   Ruilope, Luis Miguel ^b   Barrios, Vivencio ^c   Navarro, Jorge ^d   Prieto, Miguel Angel ^e   Gonzalez, Olga ^b   Guerrero, Lucía ^b   Sanchez Zamorano, Miguel Angel ^f   Filozof, Claudia ^f  

^a Hospital del SAS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d Primary Care Pediatric Clinic   (Spain)

^e Vallobin Concinos Health Center ^*  (Spain)

^f BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BODY MASS; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIABETES MELLITUS; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

EID: 33845253641     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080914     Document Type: Conference Paper

References (30)

1. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney In 63: 1121-1129, 2003
2. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
3. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation 112: 969-975, 2005
4. Madison JR, Spies C, Schatz IJ, Masaki K, Chen R, Yano K, Curb JD: Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up: The Honolulu Heart Program. Arch Intern Med 166: 884-889, 2006
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
6. Foley RN, Wang C, Collins AJ: Cardiovascular risk factor profiles and kidney function stage in the US general population: The NHANES III study. Mayo Clin Proc 80: 1270-1277, 2005
7. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850, 2004
8. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001
9. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, Berthoux F: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37: 720-727, 2001
10. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM: Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46: 871-880, 2005
11. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
13. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome: A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480, 2006
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
15. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
16. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003
17. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P: Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16: 763-773, 2005
18. Cirillo M, Anastasio P, De Santo NG: Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant 20: 1791-1798, 2005
19. Rigalleau V, Lasseur C, Perlemoine C, Barthe N, Raffaitin C, Liu C, Chauveau P, Baillet-Blanco L, Beauvieux MC, Combe C, Gin H: Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation? Diabetes Care 28:838-843, 2005
20. de Francisco AL, Otero A: Occult chronic renal failure: EPIRCE study. Nefrologia 25[Suppl 4]: 66-71, 2005
21. Garg AX, Mamdani M, Juurlink DN, van Walraven C; Network of Eastern Ontario Medical Laboratories (NEO-MeL): Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance. J Am Soc Nephrol 16: 1433-1439, 2005
22. Jabary NS, Martin D, Munoz MF, Santos M, Herruzo J, Gordillo Bustamante J: Serum creatinine and creatinine clearance to estimate renal function in essential hypertension. Nefrologia 26: 64-73, 2006
23. Redon J, Cea-Calvo L, Lozano JV, Fernandez-Perez C, Navarro J, Bonet A, Gonzalez-Esteban J; Investigators of the ERIC-HTA 2003 Study: Kidney function and cardiovascular disease in the hypertensive population: The ERIC-HTA study. J Hypertens 24: 663-669, 2006
24. Redon J, Morales-Olivas F, Galgo A, Brito MA, Mediavilla J, Marin R, Rodriguez P, Tranche S, Lozano JV, Filozof C; the MAGAL group: Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension. J Am Soc Nephrol 17[Suppl 3]: 236-245, 2006
25. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278: F817-F822, 2000
26. Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 26: 610-615, 1995
27. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D: Obesity and prevalent and incident CKD: The Hypertension Detection and Follow-Up Program. Am J Kidney Dis 46: 587-594, 2005
28. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Postano V, Buzzigoli E, Ghione S, Turchi S, Lombardi M, Ferrannini E: Visceral fat in hypertension: Influence on insulin resistance and beta-cell function. Hypertension 44: 127-133, 2004
29. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE; PREVEND Study Group: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41: 733-741, 2003
30. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005